Organigram Global Inc Revenue per Employee (OGI), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Organigram Global Inc   (NASDAQ: OGI)
 

Organigram Global Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 62.15% in the fourth quarter 2025, year on year to cumulative value of $199 million, Organigram Global Inc 's revenue per employee grew on a trailing twelve months basis to $ 248,168, this marks a new company high.
Within the Healthcare sector Employees of 370 other companies have achieved higher revenue per employee. While Organigram Global Inc 's total ranking has deteriorated compared to the previous quarter from to 2861. Organigram Global Inc has 800 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OGI Revenue per Employee (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2024)
IV. Quarter
Y / Y Revenue Change 62.15 % - - - 9.62 %
Sales per Employee (TTM) $ 248,168 153,048 153,048 153,048 153,048
OGI's Total Ranking # 2861 # # # 3857 # 3354
Seq. Revenue Change - - - - -

OGI Company Profile >> Back to OGI Efficiency Comparisons >> Compare OGI Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 156
Healthcare Sector # 371
Overall Market # 2861

Revenue per Employee Statistics
High Average Low
$ 248,168 $ 200,608 $ 153,048
(Sep 30 2025)   (Sep 30 2024)



Financial Statements
Organigram Global Inc 's Revenue MRQ $ 199 Millions Visit OGI's Income Statement
Organigram Global Inc 's Revenues TTM $ 199 Millions Visit OGI's aggregate revenue growth
What are OGI's Sales? Visit OGI's Sales by Segment




Other Ratios
Organigram Global Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
OGI's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for OGI's Competitors
Revenue per Employee for OGI's Suppliers
Revenue per Employee for OGI's Customers

You may also want to know
OGI's Sales Growth Rates OGI's Pe Price to earnings ratio OGI's Receivables Turnover Ratio OGI's Stock Quote
OGI's Net Income Growth Rates OGI's Ps Price to Sales ratio OGI's Sales per Employee OGI's Asset Turnover Ratio
OGI's Net Margin OGI's Pb Price to Book ratio OGI's Financial Strength Ratios OGI's Dividend Payout Ratio
Date modified: 2026-06-22T16:58:57+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2025Number of Employees Sep 30 2025
Airsculpt Technologies Inc   434,033.06 $ 157.554  Million 363 
Glaukos Corp  428,831.81 $ 469.142  Million 1,094 
Exact Sciences Corporation  427,826.81 $ 3,080.353  Million 7,200 
Allurion Technologies Inc   423,829.27 $ 17.377  Million 41 
Bridgebio Pharma Inc   421,668.65 $ 353.780  Million 839 
Rhythm Pharmaceuticals Inc   421,096.62 $ 174.334  Million 414 
Solventum Corporation  420,100.00 $ 8,402.000  Million 20,000 
Xilio Therapeutics Inc   418,473.68 $ 31.804  Million 76 
Cryo cell International Inc   417,730.26 $ 31.748  Million 76 
Quidelortho Corp  417,600.00 $ 2,714.400  Million 6,500 
Beone Medicines Ltd   414,297.42 $ 4,971.569  Million 12,000 
Cervomed Inc   410,652.40 $ 6.160  Million 15 
3m Company  410,330.58 $ 24,825.000  Million 60,500 
Invivyd Inc   410,155.74 $ 50.039  Million 122 
Livanova Plc  408,941.82 $ 1,349.508  Million 3,300 
Dexcom Inc   406,756.76 $ 4,515.000  Million 11,100 
Verrica Pharmaceuticals Inc   405,644.74 $ 30.829  Million 76 
Bio techne Corp  405,455.67 $ 1,216.367  Million 3,000 
Adaptive Biotechnologies Corporation  405,054.49 $ 252.754  Million 624 
Entrada Therapeutics Inc   404,736.84 $ 61.520  Million 152 
Biofrontera Inc   403,967.39 $ 37.165  Million 92 
Tandem Diabetes Care Inc   402,332.80 $ 1,005.832  Million 2,500 
Butterfly Network Inc   401,136.36 $ 88.250  Million 220 
Sight Sciences Inc   400,209.68 $ 74.439  Million 186 
Novocure Limited  400,167.60 $ 642.269  Million 1,605 
Kura Oncology Inc   400,111.54 $ 104.029  Million 260 
Arcus Biosciences Inc   399,334.44 $ 240.000  Million 601 
Vanda Pharmaceuticals Inc   397,887.43 $ 212.074  Million 533 
Phathom Pharmaceuticals Inc   396,738.54 $ 147.190  Million 371 
Interpace Biosciences Inc   396,088.24 $ 40.401  Million 102 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.